Creekmur Asset Management »

Intellia Therapeutics shares owned by Creekmur Asset Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Creekmur Asset Management from 13F filings

Historical chart of Creekmur Asset Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Creekmur Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Creekmur Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $668k 39k 17.27
2025-06-30 $550k 59k 9.38
2025-03-31 $291k 41k 7.11

More positions owned by Creekmur Asset Management

First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFD)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFQ)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Capital Grp Fixed Incm Etf T Ultra Short Inco (CGUI)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Ishares Tr Core Msci Total (IXUS)
Caterpillar (CAT)
Pimco Etf Tr Active Bd Etf (BOND)
Capital Grp Fixed Incm Etf T Core Bond Etf (CGCB)
Global X Fds 1-3 Month T-bill (CLIP)
Amazon (AMZN)

View all positions for Creekmur Asset Management

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Morgan Stanley
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Intellia Therapeutics